Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regenerative medicine. Ocata's most advanced products are in clinical trials for the treatment of Stargardt's macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocata's intellectual property portfolio includes pluripotent stem cell platforms hESC and induced pluripotent stem cell (iPSC) and other cell therapy research programs.
View Top Employees from Ocata Therapeutics, Inc.| Website | http://www.ocata.com |
| Employees | View employees |
| Address | 33 Locke Dr, Marlborough, Massachusetts 01752, US |
| Phone | (508) 756-1212 |
| Fax | (508) 229-2333 |
| Industry | Business Services |
| Competitors | Acelity, Alliqua BioMedical, Inc., Cesca Therapeutics Inc., Osiris Therapeutics, Reapplix |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular Ocata Therapeutics, Inc. employee's phone or email?
Ocata Therapeutics, Inc. Questions
Ocata Therapeutics, Inc. is based in Marlborough, Massachusetts.
The NAICS codes for Ocata Therapeutics, Inc. are [54, 54171, 541, 541714, 5417].
The SIC codes for Ocata Therapeutics, Inc. are [87, 873].
